Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Harnessing the Disease Signatures From Endometrium and Menstrual Blood to Identify Avenues for the Treatment of Chronic Conditions Such as Endometriosis and Related Pathologies

NCT06990971 is registered in ClinicalTrials.gov with Cycle Therapeutics Ltd as lead sponsor.

NCT NCT06990971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06990971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Harnessing the Disease Signatures From Endometrium and Menstrual Blood to Identify Avenues for the Treatment of Chronic Conditions Such as Endometriosis and Related Pathologies
Lead sponsor
Cycle Therapeutics Ltd
Phase
Observational
Overall status
Not yet recruiting
Start date
June 1, 2025
Completion date
May 31, 2029
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

adenomyosis, endometriosis, endometrial cancer, endometriosis, infertility